Author
Listed:
- Dalia Amer khudhair
(Department of Pathology, College of Medicine, University of Babylon, Babylon, Iraq)
- Zainab Hayder Jaber Alkufaishi
(Department of Pathology, College of Medicine, University of Babylon, Babylon, Iraq)
- Teeb M. Jaafar Al-khafaji
(Department of Pathology, College of Medicine, University of Babylon, Babylon, Iraq)
Abstract
The imbalance in oxidant burden is defined as oxidative stress (OS), which is the most significant event in the body involved in cancer development and progression. Cancer cells are characterized by high levels of OS and higher oxidant levels. That makes a physician use a double medication strategy to regulate redox status, like pro-oxidant medication and antioxidant supplements. In fact, pro-oxidant drugs have high anti-cancer activities regarding great oxidant levels within cancer cells, while antioxidant medication for redox homeostasis was a failure in some clinical trials. In cancer cells, the redox vulnerability targeted by pro-oxidants ability to produce high-level reactive oxygen species (ROS) is essential for an anti-cancer strategy. Nevertheless, numerous harmful impacts happened by the random targets of uncontrolled therapy stimulate OS in the normal tissues, and the capacity of drug-tolerant of several cancer cells greatly restricted their more implements. The effect of ROS in tissues is revealed by protein oxidation, lipids peroxidation, and DNA mutation; all these changes contribute to histological changes. In the present review, some representative oxidative anti-cancer medications and adverse effects were explained.
Suggested Citation
Dalia Amer khudhair & Zainab Hayder Jaber Alkufaishi & Teeb M. Jaafar Al-khafaji, 2024.
"Oxidative Stress Adverse Effects in Histological Changes Induced by Anticancer Drugs: A Review Article,"
Journal of Medical and Health Studies, Al-Kindi Center for Research and Development, vol. 5(2), pages 125-132, March.
Handle:
RePEc:alk:jmhs00:v:5:y:2024:i:2:id:7429
DOI: 10.32996/jmhs.2024.5.2.16
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:alk:jmhs00:v:5:y:2024:i:2:id:7429. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Al-Kindi Center for Research and Development (email available below). General contact details of provider: https://al-kindipublisher.com/index.php/jmhs .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.